bibliographic entry 5049652 [be/5049652]
https://w3id.org/oc/corpus/be/5049652

is a
content
  • Gadelha, MR, Bronstein, MD, Brue, T, Coculescu, M, Fleseriu, M, Guitelman, M, Pronin, V, Raverot, G, Shimon, I, Lievre, KK, Fleck, J, Aout, M, Pedroncelli, AM, Colao, A. Pasireotide C2402 Study Group: pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial, Lancet Diabetes Endocrinol, 2014, 2, 11, 875, 884, DOI: 10.1016/S2213-8587(14)70169-X, PMID: 25260838
references